Literature DB >> 9117011

Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization.

E Hamelmann1, A Oshiba, J Loader, G L Larsen, G Gleich, J Lee, E W Gelfand.   

Abstract

Eosinophils play a central role in the inflammatory response associated with bronchial asthma. We studied the involvement of eosinophils in the development of airway hyperresponsiveness (AHR) in a mouse model of allergic airway sensitization. Sensitization of BALB/c mice to OVA via the airways induced allergen-specific T-cell responses, IgE production, immediate cutaneous hypersensitivity (ICH), and increased airway reactivity. Airway sensitization was associated with eosinophil infiltration of the airways and increased production of interleukin-5 (IL-5) in cultures of peribronchial lymph node cells. Treatment of OVA-challenged animals with anti-IL-5 antibody during the sensitization protocol completely abolished the infiltration of eosinophils into the lung tissue and prevented the development of AHR without affecting levels of allergen-specific IgE, cutaneous hypersensitivity and allergen-specific T cell responses. These findings demonstrate that infiltration of lung tissue by eosinophils, triggered by increased IL-5 production, is a major factor in the development of AHR in this mouse model of airway sensitization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117011     DOI: 10.1164/ajrccm.155.3.9117011

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  39 in total

1.  Inhibition of airway remodeling in IL-5-deficient mice.

Authors:  Jae Youn Cho; Marina Miller; Kwang Je Baek; Ji Won Han; Jyothi Nayar; Sook Young Lee; Kirsti McElwain; Shauna McElwain; Stephanie Friedman; David H Broide
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.

Authors:  J Schwarze; E Hamelmann; K L Bradley; K Takeda; E W Gelfand
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 3.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 4.  Importance of cytokines in murine allergic airway disease and human asthma.

Authors:  Fred D Finkelman; Simon P Hogan; Gurjit K Khurana Hershey; Marc E Rothenberg; Marsha Wills-Karp
Journal:  J Immunol       Date:  2010-02-15       Impact factor: 5.422

Review 5.  Emerging molecular phenotypes of asthma.

Authors:  Anuradha Ray; Timothy B Oriss; Sally E Wenzel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-17       Impact factor: 5.464

6.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

Review 7.  Airway smooth muscle in the pathophysiology and treatment of asthma.

Authors:  Diana C Doeing; Julian Solway
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

8.  Signal transducer and activation of transcription 6 (STAT6) regulates T helper type 1 (Th1) and Th17 nephritogenic immunity in experimental crescentic glomerulonephritis.

Authors:  S A Summers; R K S Phoon; D Odobasic; L Dewage; A R Kitching; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

Review 9.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

10.  Effect of an inhibitor of Jun N-terminal protein kinase, SP600125, in single allergen challenge in sensitized rats.

Authors:  Paul R Eynott; Li Xu; Brydon L Bennett; Alistair Noble; Sum-Yee Leung; Puneeta Nath; David A Groneberg; Ian M Adcock; K Fan Chung
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.